TrialAnnals of oncology : official journal of the European Society for Medical Oncology2026

Cabozantinib plus nivolumab and ipilimumab in previously untreated, advanced renal cell carcinoma: final results and biomarker analyses from the phase III COSMIC-313 study.

R J Motzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.